acamprosate calcium
- RxCUI
- 152761
- RxNorm name
- acamprosate calcium
- Term type
- PIN
- Status
- Active
- Updated
- 2026-10-27 19:27:43
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 042005
- Active start
- 042005
- Multiple ingredient
- NO
- Branded
- NO
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| acamprosate | 82819 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | acamprosate calcium | 1 | NAMES |
| RxNorm Name | acamprosate calcium | 1 | NAMES |
| TTY | PIN | 1 | ATTRIBUTES |
| SPL_SET_ID | 13 linked values
| 13 | CODES |
| UNII_CODE | 59375N1D0U | 1 | CODES |
| RxCUI | 152761 | 1 | CODES |
| MMSL_CODE | 2 | CODES |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ACAMPROSATE CALCIUM | ACAMPROSATE CALCIUM | Somerset Therapeutics, LLC | 1cfe4675-766f-4f1a-b1a8-96bbdacfcfa5 | 2026-07-14 | Warnings, Adverse reactions | ACAMPROSATE CALCIUM |
| acamprosate calcium | ACAMPROSATE CALCIUM | REMEDYREPACK INC. | 91769a96-3182-4e38-90c3-b22c1beae398 | 2026-05-18 | Warnings, Adverse reactions | ACAMPROSATE CALCIUM |
| Acamprosate Calcium | ACAMPROSATE CALCIUM | Major Pharmaceuticals | ae6e79c0-a307-4888-b647-1b7be4cb9127 | 2026-02-11 | Warnings, Adverse reactions | ACAMPROSATE CALCIUM |
| Acamprosate Calcium | ACAMPROSATE CALCIUM | Glenmark Pharmaceuticals Inc., USA | 43e9ef60-2d85-4394-906b-93042fea099a | 2026-01-23 | Warnings, Adverse reactions | ACAMPROSATE CALCIUM |
| Acamprosate Calcium | ACAMPROSATE CALCIUM | Bionpharma Inc., | 4473326f-79f1-61b2-e063-6294a90a17a3 | 2025-11-25 | Warnings, Adverse reactions | ACAMPROSATE CALCIUM |
| acamprosate calcium | ACAMPROSATE CALCIUM | Zydus Pharmaceuticals (USA) Inc. | 9803db35-2600-4f42-80c1-43216fd1ba3d | 2023-11-06 | Warnings, Adverse reactions | ACAMPROSATE CALCIUM |
| acamprosate calcium | ACAMPROSATE CALCIUM | Zydus Lifesciences Limited | 0c729939-d2d2-4e61-acbc-4f1646dc38c1 | 2023-11-06 | Warnings, Adverse reactions | ACAMPROSATE CALCIUM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
No records found.
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | N07BB | Drugs used in alcohol dependence | ATC1-4 | acamprosate | |
| MEDRT | D000077443 | Acamprosate | CHEM | has_ingredient | acamprosate calcium |
| MEDRT | D000077443 | Acamprosate | CHEM | has_ingredient | acamprosate |
| MEDRT | D000437 | Alcoholism | DISEASE | may_treat | acamprosate calcium |
| MEDRT | D000437 | Alcoholism | DISEASE | may_treat | acamprosate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | acamprosate calcium |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | acamprosate |
| MEDRT | D007674 | Kidney Diseases | DISEASE | ci_with | acamprosate calcium |
| MEDRT | D007674 | Kidney Diseases | DISEASE | ci_with | acamprosate |
| MEDRT | N0000000118 | GABA A Modulators | MOA | has_moa | acamprosate calcium |
| MEDRT | N0000000118 | GABA A Modulators | MOA | has_moa | acamprosate |
| MEDRT | N0000020015 | NMDA Receptor Antagonists | MOA | has_moa | acamprosate calcium |
| MEDRT | N0000020015 | NMDA Receptor Antagonists | MOA | has_moa | acamprosate |
| MEDRT | N0000009325 | Increased GABA Activity | PE | has_pe | acamprosate calcium |
| MEDRT | N0000009325 | Increased GABA Activity | PE | has_pe | acamprosate |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| CODES | SNOMEDCT | 391699001 |
| CODES | USP | m1153 |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | United States Pharmacopeia |
| SOURCES | Source | US Edition of SNOMED_CT |